inhibit monocyt hydrogen peroxid chemiluminesc measur MS patient control monocyt activ site multipl sclerosi MS demyelin local tissu injuri inflammatori respons part product toxic oxygen metabolit corticosteroid MS exacerb inadequ knowledg mechan effect new class steroid deriv glucocorticoid mineralocorticoid effect product hydrogen peroxid chemiluminesc stimul monocyt stabl MS patient age- sex-match control measur chemiluminesc group result product toxic oxygen metabolit monocyt inflammatori potenti agent effect safe treatment MS exacerb 